Group 1 - The company, Chongqing Taiji Industrial (Group) Co., Ltd., is holding its second extraordinary general meeting of shareholders in 2025 on August 6, 2025, at 14:00 [1][4] - The meeting will take place at the company's conference room located at 1201, 18 Hengshan East Road, Yubei District, Chongqing [1][4] - Shareholders can vote through the Shanghai Stock Exchange's online voting system, with voting available from 9:15 to 15:00 on the day of the meeting [1][4][5] Group 2 - The meeting will include non-cumulative voting proposals, and all A-share shareholders are eligible to vote [2][3] - The board of directors has approved the agenda for the meeting during its 29th meeting on July 9, 2025, and the details have been disclosed in various financial newspapers and the Shanghai Stock Exchange website [4][5] - There are no related shareholders that need to abstain from voting on the special resolution proposals [4] Group 3 - Shareholders must be registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, by the close of trading on July 29, 2025, to attend the meeting [5] - The company allows proxy representation for shareholders, and specific identification and authorization documents are required for attendance [5][6] - The company has provided an email contact for inquiries related to the meeting [6]

Core Points - The company, Chongqing Taiji Industry (Group) Co., Ltd., was established on December 28, 1993, and is a publicly listed company since November 18, 1997, on the Shanghai Stock Exchange [3][4][9] - The registered capital of the company is RMB 556.890744 million [3][9] - The company's business philosophy focuses on health and wellness, aiming to become a leading enterprise in traditional Chinese medicine with a strong emphasis on innovation and technology [6][14] Company Structure - The company is a permanent joint-stock company, with the chairman serving as the legal representative [4][5] - The company has established a Communist Party organization to conduct party activities within the company [6][14] - The company’s senior management includes the general manager, deputy general managers, board secretary, and financial director [5][6] Business Scope - The company’s business scope includes the production and retail of pharmaceuticals, health food production, and various medical device manufacturing [6][7] - The company is also involved in research and development in medicine and technology, as well as agricultural products [7][8] Share Structure - The company has issued a total of 556.890744 million shares, all of which are ordinary shares [9][10] - The company can increase its capital through various legal means, including public offerings and employee stock ownership plans [10][11] - The company is restricted from repurchasing its shares except under specific circumstances, such as capital reduction or mergers [10][11] Shareholder Rights - Shareholders have rights to dividends, voting, and the ability to request meetings and propose agenda items [16][17] - Shareholders holding more than 3% of shares for over 180 days can request to review the company's financial records [17][18] - The company must provide legal opinions on the validity of shareholder meetings and decisions [26][27] Governance - The company’s board of directors is responsible for major decisions, including profit distribution and capital changes [24][25] - The company must hold annual shareholder meetings within six months after the end of the fiscal year [26][27] - The company has established procedures for calling and conducting shareholder meetings, ensuring transparency and compliance with legal requirements [28][29]

Core Viewpoint - The document outlines the independent director working system of Chongqing Taiji Industry (Group) Co., Ltd., emphasizing the importance of independent directors in corporate governance and their role in protecting the interests of minority shareholders [1][2]. Summary by Sections General Principles - The system aims to standardize operations, enhance the role of independent directors, and improve corporate governance for high-quality development [1]. - Independent directors must not hold other positions within the company and should have no direct or indirect interests that could affect their independent judgment [2]. Qualifications and Appointment of Independent Directors - Independent directors must maintain independence and cannot be individuals with certain relationships or interests in the company [5]. - The board must have at least one accounting professional among the independent directors, and independent directors should not serve on more than three domestic companies [6][5]. Responsibilities and Duties of Independent Directors - Independent directors are responsible for participating in board decisions, supervising potential conflicts of interest, and providing professional advice to enhance decision-making [9]. - They have special rights, including hiring external consultants and proposing meetings [15]. Communication and Reporting - Independent directors must attend board meetings and can communicate with the board secretary to discuss agenda items [10]. - They are required to submit annual reports detailing their activities and interactions with minority shareholders [29]. Support and Compensation - The company must provide necessary working conditions and support for independent directors to fulfill their duties [31]. - Independent directors are entitled to compensation that reflects their responsibilities, and the company must cover expenses related to hiring professional services [36][19].

Core Points - The company has established an Audit Committee to enhance corporate governance and ensure compliance with relevant laws and regulations [1][2][3] - The Audit Committee is responsible for overseeing internal and external audit processes, ensuring accurate financial reporting, and maintaining effective internal controls [4][5][6] - The composition of the Audit Committee includes five members, with a majority being independent directors, and it is chaired by a professional accountant [3][4] - The committee's responsibilities include reviewing financial information, evaluating audit work, and supervising the internal audit department [9][10][11] - The company has also established a Remuneration and Assessment Committee to manage the evaluation and compensation of directors and senior management [13][14][15] - The Nomination Committee is responsible for selecting candidates for directors and senior management, ensuring a structured selection process [21][22][23] - The Strategic Committee focuses on long-term development strategies and major investment decisions, enhancing the company's core competitiveness [26][27][28]

重庆太极实业（集团）股份有限公司 董事会审计委员会实施细则 （2025 年 7 月修订） 第一章 总 则 第一条 为了推进重庆太极实业（集团）股份有限公司 （以下简称公司）提高公司治理水平,规范公司董事会审计 委员会的运作，根据《中华人民共和国公司法》（以下简称 《公司法》）、《中华人民共和国证券法》《上市公司治理准则 （2025 年修正）》《上市公司独立董事管理办法（2025 年修 正）》《上海证券交易所股票上市规则（2025 年 4 月修订）》 （以下简称《股票上市规则》）、《上海证券交易所上市公司 自律监管指引第 1 号——规范运作（2025 年 5 月修订）》等 相关法律、行政法规、部门规章、交易所业务规则以及《重 庆太极实业（集团）股份有限公司章程》（以下简称《公司 章程》）的要求，公司特设立董事会审计委员会，并制定本 实施细则。 第二条 审计委员会是董事会下设的专门委员会，对董 事会负责，向董事会报告工作，行使《公司法》规定的监事 会的职权，负责公司内、外部审计工作的监督、审核、沟通 及协调。 第三条 审计委员会成员须保证足够的时间和精力履 行委员会的工作职责，勤勉尽责，切实有效地监督公司的外 部 ...

重庆太极实业（集团）股份有限公司 章 程 二 0 二五年七月 - 1 - | 第一章 | 总则 | | --- | --- | | 第二章 | 经营宗旨和范围 - 5 - | | 第三章 | 股份 . | | 第四章 | 公司党委 - 10 - | | 第五章 | 股东和股东会 - 10 - | | 第六章 | 董事和董事会 . | | 第七章 | 高级管理人员 - 53 - | | 第八章 | 财务会计制度、利润分配和审计 - 56 - | | 第九章 | 通知和公告 | | 第十章 | 合并、分立、增资、减资、解散和清算 - 65 - | | | 第十一章 修改章程 | | | 第十二章 附则 | 第一章 总 则 第一条 为维护重庆太极实业（集团）股份有限公司（以 下简称公司）、股东、职工和债权人的合法权益，规范公司的组 织和行为，根据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）和其他有关 规定，制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股 份有限公司。 公司于 1993 年 12 月 28 日在涪陵市工商行政管理局注册登 记，取得营 ...

重庆太极实业（集团）股份有限公司 独立董事专门会议议事规则 （2025 年 7 月修订） 第一章 总 则 第一条 为进一步完善重庆太极实业（集团）股份有限公司（以 下简称"公司"）治理结构，促进公司的规范运作，保护公司及中小 股东的合法权益，根据《公司法》《上市公司治理准则（2025 修正）》 《上市公司独立董事管理办法(2025 修正)》《上海证券交易所上市公 司自律监管指引第 1 号—规范运作(2025 年 5 月修订)》等法律、行 政法规、规范性文件及《重庆太极实业（集团）股份有限公司章程》 （以下简称《公司章程》）《重庆太极实业（集团）股份有限公司独立 董事工作制度》等有关规定，结合公司实际情况，制定本议事规则。 第二条 独立董事专门会议（以下简称"专门会议"）是指全部由 公司独立董事参加的会议。 独立董事是指不在公司担任除董事外的其他职务，并与公司及其 主要股东、实际控制人不存在直接或者间接利害关系，或者其他可能 影响其进行独立客观判断关系的董事。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务，应当 按照法律、行政法规、中国证监会、上海证券交易所业务规则、《公 司章程》和本议事规则的规定，认真 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-046 重庆太极实业（集团）股份有限公司 关于变更会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 拟聘任的会计师事务所名称：立信会计师事务所（特殊普通合 伙）（以下简称： "立信会计师事务所"） 原聘任的会计师事务所名称：天健会计师事务所（特殊普通合 伙）（以下简称： "天健会计师事务所"） 变更会计师事务所的简要原因及前任会计师的异议情况：鉴于 原审计机构天健会计师事务所服务期限已满，根据《国有企业、上市 公司选聘会计师事务所管理办法》（财会〔2023〕4 号）等相关规定， 为保证审计工作的独立性和客观性，经公司邀请招标，拟聘任立信会 计师事务所为公司 2025 年度财务报告和内部控制审计机构。公司已 就上述变更事项与前任会计师事务所进行了事先沟通，前任会计师事 务所知悉本次变更事项并确认无异议。 一、拟聘任会计师事务所的基本情况 （一）机构信息 1.基本信息 | 事务所名称 | 立信会计师事务所（特殊普通合伙）） | | ...

证券代码：600129 证券简称：太极集团 公告编号：2025-050 重庆太极实业（集团）股份有限公司 关于取消监事会并修订《公司章程》及相 关制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司）于 2025 年7月7日召开了第十届董事会第二十九次会议及第十届监事会第二 十四次会议，审议通过了《关于取消监事会并修订<公司章程>的议案》 《关于修订部分公司治理制度的议案》，现将具体情况公告如下： 一、取消监事会并修订《公司章程》的原因及依据根据 根据《中华人民共和国公司法（2023 年修订）》（以下简称《公 司法》）、《上市公司章程指引（2025 年修订）》（以下简称《章 程指引》）等相关法律法规的规定，结合公司实际情况，公司将不再 设置监事会，监事会的职权由董事会审计委员会行使，相应废止《监 事会议事规则》，并对《公司章程》及其附件《股东会议事规则》和 《董事会议事规则》进行相应修订，同时也修订部分议事规则及管理 制度。 在公司股东大会审议通过取消监事会设置事项前， ...

证券代码：600129 证券简称：太极集团 公告编号：2025-048 重庆太极实业（集团）股份有限公司 关于注销间接控股子公司的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司或太极集 团）于2025年7月7日召开了第十届董事会第二十九次会议，审议通过 了《关于拟注销控股子公司的议案》，同意简易注销间接控股子公司 海南太极医药保健品进出口有限公司（以下简称：海南医保进出口公 司）。 根据《上海证券交易所股票上市规则》《上市公司重大资产重组 管理办法》的有关规定，注销间接控股子公司海南医保进出口公司公 司不构成重大资产重组，本事项无需提交公司股东大会审议。 一、拟清算注销公司基本情况 1.基本信息 二、本次拟注销的原因 为进一步聚焦主责主业，优化公司资源配置及资产结构，提高运 营效率，结合公司实际经营情况，拟简易注销海南医保进出口公司。 公司名称：海南太极医药保健品进出口有限公司 成立时间：2018 年 7 月 26 日 注册资本：300 万元 注册地址：海南省屯昌县屯城 ...